Featured News Item

Akouos Featured in Wall Street Journal: “Cures for Hearing Loss May Be Found in New Drugs”

Learn More
  • Filter By:

NewsAkouos Featured in Wall Street Journal: “Cures for Hearing Loss May Be Found in New Drugs”
PressAkouos Launches The Sing Registry to Inform Future Therapeutic Development for Genetic Sensorineural Hearing Loss
PressAkouos Discloses Lead Program, AK-OTOF, a Potential Gene Therapy for Sensorineural Hearing Loss
PressAkouos Announces Executive Leadership Team Appointments
PressAkouos to Participate in Upcoming Investor Conferences
NewsAkouos CEO Manny Simons Among Genetic Engineering & Biotechnology News’ Top 10 Under 40 of 2019
PressAkouos Announces New Data at the American Society of Gene & Cell Therapy 2019 Annual Meeting
NewsAkouos Among Biospace’s Top 20 Life Science Startups to Watch in 2019
NewsTo hear a whisper: biotechs chase new thinking to restore hearing
NewsNEA, 5AM back a $50M play to steer gene therapies to the clinic at Akouos — the latest startup in hearing
NewsAkouos raises $50 million to develop gene therapies for hearing loss
NewsMusician-scientist Manny Simons and Akouos seek way to treat a gene-based hearing loss
PressAkouos Raises $50 Million Series A Financing and Expands Team to Advance Precision Genetic Therapies That Restore and Preserve Hearing
PressAkouos to Build Premier Gene Therapy Company Focused on Hearing and Balance Disorders with Backing from Leading Life Science Investors and Strategic Licenses from Massachusetts Eye and Ear and Lonza
PressGene therapy restores auditory and vestibular function in a mouse model of Usher syndrome type 1c
PressA synthetic AAV vector enables safe and efficient gene transfer to the mammalian inner ear